Kraig Biocraft Laboratories Inc (KBLB)

[gimmegimmeminemine]

In mid 2019, the SP reached $0.45, or so. Primarily, it happened on the prospect of uplisting to a better exchange, presumably NASDAQ

That is not accurate in the least.

The uplist plan crashed the the share price from an all time high of .507

Primarily because of the significant reverse split that would have been required to qualify for an uplist.

It was premature and a poor decision by the CEO at the time.

Which has been confirmed by the lack of production since the uplist plan.

That being said, the share price would have slumped anyways as the imminent production the company portrayed never came.